Lonza has successfully completed the acquisition of Roche’s large-scale biologics manufacturing site in Vacaville, California for 1.2 billion dollars. With a total bioreactor capacity of around 330,000 liters, the Vacaville site is claimed to be one of the largest biologics manufacturing facilities in the world.
Read on